Select Bibliography

Filter by any of these (after searching):

Kelly, William Kevin

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 13 items

The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy with Docetaxel in Patients with Metastatic Castrate Resistant Prostate Cancer: Results from a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)

Aggarwal, Rahul , Halabi, Susan , Kelly, William Kevin ... - - Cancer - 2013

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90401

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - JAMA Oncol - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Health Outcomes - CALGB-30607 , CALGB-30610 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-70501 , CALGB-70604 , CALGB-80405 , CALGB-90401

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

Halabi, Susan , Kelly, William Kevin , Ma, Hua , Zhou, Haojin ... - - J Clin Oncol - 2016

Manuscript - Secondary-not-in-original - Meta-Analysis - GU - CALGB-90601

The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials.

Halabi, Susan , Kelly, William Kevin , Zhou, Haojin ... - ASCO - J Clin Oncol - 2014

Abstract - Secondary-not-in-original - Meta-Analysis - GU - CALGB-90401 , SWOG-S9916

Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy

Hertz, Daniel L. , Owzar, Kouros , Lessans, Sherrie , Wing, Claudia ... - - Clin Cancer Res - 2016

Manuscript - Primary - Primary - PPP - CALGB-60404 , CALGB-90401

A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance).

Hertz, Daniel Louis , Jiang, Chen , Owzar, Kouros , Halabi, Susan ... - ASCO - J Clin Oncol - 2014

Abstract - Primary - Primary - PPP - CALGB-60404 , CALGB-90401

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients (Alliance)

Innocenti, Federico , Wang, Jin , Sibley, Alexander B. , Jiang, Chen ... - ENA / AACR - MTCT - European Journal of Cancer - 2020

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-40502 , CALGB-40503 , CALGB-80303 , CALGB-90401

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

Kelly, William Kevin , Halabi, Susan , Carducci, Michael ... - - J Clin Oncol - 2012

Manuscript - Primary - Primary - GU - CALGB-90401

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.

Kelly, William Kevin , Halabi, Susan , Elfiky, Aymen , Ou, San-San ... - - Cancer - 2008

Manuscript - Primary - Primary - GU - CALGB-99811

Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

Li, Megan , Mulkey, Flora , Jiang, Chen , O'Neil, Bert H. ... - - Clin Cancer Res - 2018

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-80405 , CALGB-90401 , ECOG-E5103

Bevacizumab (BEV) and risk of hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401 (Alliance).

Patel, Jai Narendra , Jiang, Chen , Hertz, Daniel Louis ... - ASCO - J Clin Oncol - 2014

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90401

Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance)

Quintanilha, Julia C. F. , Liu, Yingmiao , Etheridge, Amy S. ... - - Angiogenesis - 2022

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80303 , CALGB-90401

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

Quintanilha, Julia C. F. , Wang, Jin , Sibley, Alexander B. ... - - Br J Cancer - 2022

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-40503 , CALGB-80303 , CALGB-90401